Evidence map›Paper›PMID 24732400›Full record

ArticleThe Journal of investigative dermatology2014

Loss of collagen VII is associated with reduced transglutaminase 2 abundance and activity.

Victoria Küttner, Claudia Mack, Christine Gretzmeier, Leena Bruckner-Tuderman, Jörn Dengjel

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. The Role of Fibroblasts in Dystrophic Epidermolysis Bullosa Pathogenesis and Current Treatment Approaches.JID innovations : skin science from molecules to population health · 2025
    Review
  4. Article
  5. Article
  6. Collagen VII maintains proteostasis in dermal fibroblasts by scaffolding TANGO1 cargo.Matrix biology : journal of the International Society for Matrix Biology · 2022
    Article
  7. A functional outside-in signaling network of proteoglycans and matrix molecules regulating autophagy.Matrix biology : journal of the International Society for Matrix Biology · 2021
    Article
  8. Review
  9. Review
  10. Signatures of Dermal Fibroblasts from RDEB Pediatric Patients.International journal of molecular sciences · 2021
    Article
  11. Review
  12. Review
  13. Observational
  14. Targeting defective proteostasis in the collagenopathies.Current opinion in chemical biology · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Victoria KüttnerDepartment of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany; Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, Freiburg, Germany; ZBSA Center for Biological Systems Analysis, University of Freiburg, Freiburg, Germany.
Claudia MackDepartment of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany.
Christine GretzmeierDepartment of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany; Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, Freiburg, Germany; ZBSA Center for Biological Systems Analysis, University of Freiburg, Freiburg, Germany.
Leena Bruckner-TudermanDepartment of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany; Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, Freiburg, Germany; ZBSA Center for Biological Systems Analysis, University of Freiburg, Freiburg, Germany; BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany.
Jörn DengjelDepartment of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany; Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, Freiburg, Germany; ZBSA Center for Biological Systems Analysis, University of Freiburg, Freiburg, Germany; BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany. Electronic address: joern.dengjel@medizin.uni-freiburg.de.
University of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Absence of collagen VII leads to widespread cellular and tissue phenotypes. However, the underlying molecular mechanisms are not well understood. To gain insights into cellular responses to loss of collagen VII, we undertook a quantitative disease proteomics approach. By using recessive dystrophic epidermolysis bullosa (RDEB), a skin blistering disease caused by collagen VII deficiency, as a genetic model, collagen VII-dependent differences in cellular protein abundances and protein-protein interactions were analyzed. Absence of collagen VII led to alterations of intracellular protein compositions and to perturbations in cell adhesion, protein trafficking, and the turnover pathway autophagy. A potential linker of the different cellular phenotypes is transglutaminase 2 (TGM2), a multifunctional enzyme important for protein cross-linking. TGM2 was identified as a stable interaction partner of collagen VII. In RDEB, both abundance and activity of TGM2 were reduced, accounting not only for diminished adhesion and perturbed autophagy but also for reduced cross-linking of the extracellular matrix and for decreased epidermal-dermal integrity in RDEB.

Indexed as

Epidermolysis Bullosa DystrophicaAutophagyCell AdhesionCollagen Type VIIDermisEnzyme ActivationEpidermal CellsEpidermisFibroblastsGTP-Binding ProteinsHumansInfant, NewbornPhenotypePrimary Cell CultureProtein Glutamine gamma Glutamyltransferase 2ProteomeCOL7A1 protein, humanCollagen Type VIIGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2ProteomeTGM2 protein, humanTransglutaminases

Identifiers

PMID24732400
OpenAlexW1999004381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.